Greater Cambridge Area
I trained in medicine at the University of Cambridge, UK, gaining first class honours/distinction in each of six years. Since then, I have been an academic junior doctor in the NHS; gained distinction in a translational medicine MPhil at the University of Cambridge; and, almost uniquely within the UK, trained as a specialist registrar doctor in both dermatology and clinical pharmacology & therapeutics. I gained 6 dermatology prizes/scholarships during my training - including from Cambridge University, the British Photodermatology Group, the European Academy for Dermatology and Venereology, and the British Association of Dermatology. Within the NHS, I worked as both an honorary and locum consultant dermatologist at Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital) up until December 2025 - carrying out adult general medical and surgical dermatology clinics. I now work clinically at the Spire Cambridge Lea Hospital, in private practice. I have a particular interest in inflammatory conditions such as psoriasis, seborrhoeic dermatitis, atopic dermatitis/eczema, vitiligo, hair loss and chronic hand eczema; as well as in skin cancer detection and its early treatment. I have previously worked as both a study physician and dermatology advisor with GSK, on a number of clinical trials. In April 2020 I joined a biotech company called Evelo Biosciences, starting as a study clinical lead and leaving as VP of clinical development and the overall project lead for two drug candidates. I led phase I and phase II clinical trials across different indications, from study concept through to study completion and results dissemination. I led the agency interactions with MHRA, EMA and FDA. I managed the development team across medical, clinical operations, database management and statistics, and held leadership positions within the company within the extended executive and leadership teams. In October 2023 I joined Leo Pharma in the global medical affairs team, acting as global principal medical advisor responsible for the post-launch phase of a biologic. In February 2024 I joined the team working with a pre-launch topical product, working with the US on their medical launch strategy and implementation, eventually co-leading the US launch of this product. In October 2025 I was promoted to senior medical director, portfolio - now managing the portfolio of products for US medical affairs and leading 3 teams.
I was promoted in October 2025 to this role to lead 3 teams within US medical affairs across the portfolio of products.
I transitioned from the global medical affairs team to the US medical affairs team to help drive the launch of a topical product in the US.
I joined Leo Pharma in October 2023 as Global Principal Medical Advisor, working first in post-launch , and then switching to a pre-launch product.
Honorary Consultant in Dermatology at Addenbrooke's Hospital, Cambridge, UK. Particular interests include clinical trials research, medication safety, management of inflammatory skin diseases such as psoriasis, atopic dermatitis, chronic hand eczema, blistering diseases and HS, and also the early detection and treatment of skin cancers.
Specialisation: Clinical Pharmacology and Therapeutics, with particular interest in clinical trials research and translational medicine
• Overall accountability for lead product candidates, across the Phase 1 and 2 program in psoriasis, atopic dermatitis and COVID-19 • A member of Clinical Leadership Team, Extended Leadership Team, and Extended Executive Team (EET), with a key role in strategic planning, organizational direction, and personnel development. • Line manager responsible for the clinical development and clinical operations team. • Clinical trial strategy, design, execution, results analysis, and presentation. This includes: o Designing and writing protocols from first-in-human studies through to phase 2 clinical trials o Acting as sponsor medical monitor for phase 1 and 2 studies, and oversight of medical monitor o Designing and leading safety review committees/data monitoring committees o Phase 3 clinical trial planning o Clinical lead on medical writing (e.g., briefing book, IB, pediatric plan, manuscripts) • Clinical lead for regulatory interactions/discussions with MHRA, EMA and FDA